why choose us

First received: June 06, 2025

Clinical Trial: Bioavailability and Bioequivalence Study of Extended Release Torsemide and Spironolactone

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Bioavailability Heathy Volunteers

Study Type: INTERVENTIONAL


Official Title: Bioavailability and Bioequivalence (BA/BE) Study of Extended Release (ER) Torsemide and Spironolactone Fixed Dose Combination (FDC) Tablet in Healthy Adult Human Subjects

Brief Summary: To study intrasubject variability and steady-state pharmacokinetics of multiple-doses of Extended Release Torsemide and Spironolactone Fixed Dose Combination (FDC) tablets given together in healthy adult subjects.

Read more